NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) ("Hydreight" or the "Company"), a leader in U.S. nationwide digital healthcare solutions, is pleased to announce that, further to the news release of the Company dated January 15, 2026, it has closed its previously announced "bought deal" private placement with Canaccord Genuity Corp. ( ...

Core Insights - Hydreight Technologies Inc. has exceeded its operational target for 2025 by surpassing 1.3 million product orders placed ahead of year-end, reflecting strong platform adoption and partner demand [4][10][11] - The company has expanded its ecosystem to approximately 2,500 licenses, significantly exceeding its target of 1,000 for 2025, although many licenses are still in onboarding stages [7][10] - The focus remains on long-term value creation and disciplined execution as the company prepares for increased platform activity in 2026 [9][10][15] Operational Highlights - VSDHOne, the enterprise-focused vertical, began commercial activity in late June 2025 and has been progressively scaled [3] - The company achieved over 1.3 million product orders placed, surpassing its 2025 operational target, driven primarily by an initial base of approximately 400 fully onboarded licenses [4][10] - Hydreight continues to use product orders placed as its primary operational metric, reflecting real-time platform activity and demand [5][23] License and Platform Expansion - The company supports around 2,500 licenses, with the majority still in onboarding or early activation stages, which are not yet contributing significantly to order volume [7][10] - Management anticipates that utilization will scale progressively as onboarding is completed, positioning the company for increased activity in 2026 [7][15] Average Order Value and Strategic Focus - Average order value (AOV) reflects the early-stage scaling of newer offerings, with a focus on balancing order volume and product mix for long-term value creation [9][10] - The company is committed to building a durable and scalable business, with expectations for platform metrics to evolve as newer verticals mature [10] 2026 Guidance and Future Outlook - Hydreight plans to provide formal 2026 guidance early in the new year, following a review of several strategic initiatives, including enterprise partnerships and M&A opportunities [12][14] - The company is evaluating late-stage opportunities for enterprise customers, which will be incorporated into future guidance for a more accurate business outlook [13][14] Recognition and Growth - Hydreight was ranked as the 56th fastest-growing company in North America on the 2024 Deloitte Technology Fast 500™ and recognized as a top 50 TSX Venture Exchange company [16] - The company is expanding high-volume platform partners and increasing utilization across multiple healthcare categories, while also strengthening compliance and governance [16]

Core Viewpoint - Hydreight Technologies Inc. has successfully closed a private placement of unsecured convertible debentures, raising gross proceeds of C$11,500,000 to support its growth strategy and operational efficiency [1][4]. Group 1: Offering Details - The company issued a total of 11,500 convertible debentures at an issue price of C$1,000 each, including 1,500 debentures sold under the agent's over-allotment option [1]. - The debentures are unsecured, maturing on September 4, 2028, with an annual interest rate of 9.0%, payable semi-annually starting December 31, 2025 [2]. - Holders of the debentures can convert them into common shares at a conversion price of C$4.06 per share [2]. Group 2: Forced Conversion Right - The company has the option to force the conversion of the debentures if the volume-weighted average trading price of its common shares exceeds C$5.08 for 20 consecutive trading days [3]. - A notice will be provided to debenture holders if the forced conversion right is exercised, specifying the conversion date, which will be at least 30 days after the notice [3]. Group 3: Financial and Operational Insights - The CEO highlighted that the company has reached profitability as reflected in its Q2 financials and emphasized the importance of this funding for accelerating growth [4]. - The net proceeds from the offering will be utilized for general corporate and working capital purposes [5]. Group 4: Company Overview - Hydreight Technologies Inc. is developing a large mobile clinic network in the U.S., with a platform that connects over 2,500 nurses and 100 doctors across all 50 states [8]. - The platform includes integrated tools for healthcare professionals to provide services directly to patients, enhancing convenience and compliance [8].

Core Viewpoint - Hydreight Technologies Inc. has announced a private placement offering of up to C$10,000,000 in unsecured convertible debentures to support its digital healthcare solutions business [1][6] Group 1: Offering Details - The company has granted Canaccord Genuity Corp. an option to increase the offering size by up to C$1,500,000 [2] - The debentures will mature 36 months from issuance and are convertible into common shares at a price of C$4.06 per share [3] - The offering is expected to close around September 4, 2025, pending regulatory approvals [6] Group 2: Financial Terms - The debentures will bear a fixed interest rate of 9.0% per annum, payable semi-annually [5] - The company will pay a cash commission of 6.0% to the lead agent and issue compensation warrants equal to 6.0% of the number of shares issuable upon conversion [7] Group 3: Company Overview - Hydreight Technologies Inc. is building a large mobile clinic network in the U.S., with over 2,500 nurses and 100 doctors across 50 states [10] - The company's platform includes integrated tools for healthcare professionals to provide services directly to patients [10]